L. Runkel

发表

The structure of human interferon-β: implications for activity

A. Whitty, M. Karpusas, L. Runkel, 1998, Cellular and Molecular Life Sciences CMLS.

Mapping of IFN-beta epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substitution mutagenesis.

D. Baker, A. Whitty, M. Zafari, 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit

M. Fischer, H. Schaller, L. Runkel, 2005, Virus Genes.

Costimulatory pathway targets for autoimmune and inflammatory conditions: clinical successes, failures, and hope for the future

L. Runkel, P. Spicer, 2019, Expert opinion on investigational drugs.

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice.

F. Chisari, R. Schreiber, T. Ishikawa, 1994, Proceedings of the National Academy of Sciences of the United States of America.

TWEAK Is a Novel Arthritogenic Mediator

M. Scott, T. Zheng, H. Hess, 2006, The Journal of Immunology.

IFN-α2 Induces Leukocyte Integrin Redistribution, Increased Adhesion, and Migration

G. Foster, Yan Gu, G. Lombardi, 2007 .

THE NUCLEOTIDE SEQUENCE OF pACYC 177

L. Runkel, K. Rushlow, D. Kuebbing, 1982 .

Characterization of antihuman IFNAR-1 monoclonal antibodies: epitope localization and functional analysis.

L. A. Goldman, M. Zafari, C. Benjamin, 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Chemical footprinting of the interaction between left-handed Z-DNA and anti-Z-DNA antibodies by diethylpyrocarbonate carbethoxylation.

A. Nordheim, L. Runkel, 1986, Journal of molecular biology.

Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).

A. Whitty, S. Goelz, M. Karpusas, 1998, Pharmaceutical research.

Lupus clinical development: will belimumab's approval catalyse a new paradigm for SLE drug development?

L. Runkel, J. Stacey, 2014, Expert opinion on biological therapy.

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage

P. Galle, W. Stremmel, P. Krammer, 1995, The Journal of experimental medicine.

Two-codon insertion mutations of the HBx define two separate regions necessary for its trans-activation function.

M. Fischer, H. Schaller, L. Runkel, 1993, Virology.

DNA sequences of the D-serine deaminase control region and N-terminal portion of the structural gene

L. Runkel, E. McFall, 1983, Journal of bacteriology.

Isolation and characterization of cDNAs for the protein kinase HIPK2.

T. Haaf, H. Hug, K. Debatin, 2001, Biochimica et biophysica acta.

TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model

H. Iocca, J. Ting, L. Burkly, 2008, Journal of Neuroimmunology.

Multiple basal promoter elements determine the level of human c-fos transcription

R. Hipskind, A. Nordheim, P. Shaw, 1991, Molecular and cellular biology.

Mutations Leading to X-linked Hypohidrotic Ectodermal Dysplasia Affect Three Major Functional Domains in the Tumor Necrosis Factor Family Member Ectodysplasin-A*

J. Tschopp, P. Schneider, A. Tardivel, 2001, The Journal of Biological Chemistry.

Structural and Functional Differences Between Glycosylated and Non-glycosylated Forms of Human Interferon-β (IFN-β)

Adrian Whitty, Werner Meier, A. Whitty, 1998, Pharmaceutical Research.

Characterization of a soluble ternary complex formed between human interferon‐β‐1a and its receptor chains

Wei Cheng, D. Baker, R. Arduini, 1999, Protein science : a publication of the Protein Society.

The structure of human interferon-beta: implications for activity.

A. Whitty, M. Karpusas, L. Runkel, 1998, Cellular and molecular life sciences : CMLS.

Interferon-β Induces S Phase Accumulation Selectively in Human Transformed Cells

J. Barsoum, L. Runkel, X. Qin, 1997 .

Differences in Activity between α and β Type I Interferons Explored by Mutational Analysis*

L. Pfeffer, S. Goelz, S. Pellegrini, 1998, The Journal of Biological Chemistry.

TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.

M. Scott, J. Shearstone, L. Burkly, 2009, Gastroenterology.

Systematic mutational mapping of sites on human interferon-beta-1a that are important for receptor binding and functional activity.

A. Whitty, M. Zafari, C. Benjamin, 2000, Biochemistry.

Interferon-beta induces S phase accumulation selectively in human transformed cells.

J. Barsoum, L. Runkel, X. Qin, 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Conformational DNA transition in the in vitro torsionally strained chicken beta-globin 5' region.

A. Nordheim, L. Runkel, 1986, Nucleic acids research.

TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model

H. Iocca, J. Ting, L. Burkly, 2008, Journal of Neuroimmunology.